SANTINI, DAVIDE
 Distribuzione geografica
Continente #
AS - Asia 2.851
NA - Nord America 1.842
EU - Europa 1.109
AF - Africa 135
SA - Sud America 125
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.065
Nazione #
US - Stati Uniti d'America 1.803
VN - Vietnam 1.140
SG - Singapore 603
CN - Cina 516
IT - Italia 315
HK - Hong Kong 209
SE - Svezia 139
DE - Germania 129
GB - Regno Unito 98
KR - Corea 86
BR - Brasile 85
FR - Francia 78
IN - India 66
FI - Finlandia 65
BD - Bangladesh 59
NL - Olanda 54
IE - Irlanda 53
CI - Costa d'Avorio 49
CH - Svizzera 46
JP - Giappone 29
RU - Federazione Russa 28
AT - Austria 26
SC - Seychelles 26
TG - Togo 22
JO - Giordania 21
PH - Filippine 21
CA - Canada 20
BG - Bulgaria 19
PL - Polonia 19
AR - Argentina 18
ID - Indonesia 17
NG - Nigeria 13
TH - Thailandia 13
PK - Pakistan 11
TW - Taiwan 11
MX - Messico 10
ZA - Sudafrica 10
IQ - Iraq 9
SA - Arabia Saudita 9
TR - Turchia 9
UA - Ucraina 8
BE - Belgio 7
ES - Italia 7
CO - Colombia 6
EC - Ecuador 5
VE - Venezuela 5
LT - Lituania 4
OM - Oman 4
PY - Paraguay 4
UZ - Uzbekistan 4
TN - Tunisia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
CZ - Repubblica Ceca 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
LB - Libano 2
ML - Mali 2
MU - Mauritius 2
NI - Nicaragua 2
NP - Nepal 2
PT - Portogallo 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
MA - Marocco 1
MK - Macedonia 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.065
Città #
Singapore 400
Ho Chi Minh City 316
Ashburn 256
Hanoi 255
Hong Kong 190
San Jose 182
Hefei 146
Chandler 133
Santa Clara 106
Bologna 93
Fairfield 79
Seoul 74
Los Angeles 73
Beijing 67
Southend 66
Dallas 62
Da Nang 58
Dublin 53
Boardman 52
Abidjan 49
New York 49
Helsinki 47
Bern 46
Seattle 43
Haiphong 41
Houston 36
Council Bluffs 35
Woodbridge 35
Princeton 33
Lauterbourg 29
Cambridge 28
Munich 27
Tokyo 24
Turin 24
Buffalo 22
Lomé 22
Wilmington 22
Amman 21
Bến Tre 20
Biên Hòa 19
Sofia 19
Thái Nguyên 18
Redondo Beach 17
Vienna 17
Milan 16
Florence 15
Frankfurt am Main 15
Berlin 14
Can Tho 14
Shanghai 14
Bengaluru 13
São Paulo 13
Abeokuta 12
Chicago 12
Falkenstein 12
Guangzhou 12
Orem 12
Redmond 12
Warsaw 12
Hải Dương 11
Quận Bình Thạnh 11
Bắc Ninh 10
Lappeenranta 10
Amsterdam 9
Jakarta 9
London 9
Phoenix 9
Shenzhen 9
Vũng Tàu 9
Westminster 9
Ann Arbor 8
Bắc Giang 8
Montreal 8
Nha Trang 8
Ninh Bình 8
Nuremberg 8
Rimini 8
The Dalles 8
Thái Bình 8
Bremen 7
Brussels 7
Quận Một 7
Rome 7
Toronto 7
Turku 7
Tân Tiến 7
Washington 7
Charlotte 6
Des Moines 6
Huế 6
Hyderabad 6
Mexico City 6
Quận Bảy 6
Stockholm 6
Boston 5
Cao Lanh 5
Changsha 5
Chengdu 5
Denver 5
Genoa 5
Totale 3.907
Nome #
Comparison of Pathological Scores for Predicting Metastasis in Pheochromocytoma and Paraganglioma: a Single-Center Experience. 336
Arid1a and ctnnb1/β-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: Implications for an improved surrogate molecular classification 240
Computerized tomography texture analysis of pheochromocytoma: relationship with hormonal and histopathological data 239
Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics 222
HPV DNA Associates With Breast Cancer Malignancy and It Is Transferred to Breast Cancer Stromal Cells by Extracellular Vesicles 219
Grade group system and plasma androgen receptor status in the first line treatment for metastatic castration resistant prostate cancer 215
Bone metastases in biliary cancers: A multicenter retrospective survey 202
Relevance of ARID1A Mutations in Endometrial Carcinomas 197
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 185
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 185
Pancreatic ductal adenocarcinoma associated with autoimmune pancreatitis. 180
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer 173
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib 171
Large−Scale Profiling of Extracellular Vesicles Identified miR−625−5p as a Novel Biomarker of Immunotherapy Response in Advanced Non−Small−Cell Lung Cancer Patients 169
A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed 166
Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline ☆ 165
Mesonephric-like adenocarcinomas of the ovary: pathological and molecular characterisation of a case series. 164
Atypical fibroxanthoma associated with differentiated-type vulvar intraepithelial neoplasia: Case report of an unusual entity 159
An exceptional case of primary ovarian angiosarcoma 158
The Italian Rare Pancreatic Exocrine Cancer Initiative 158
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 157
Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice—a fifteen-year journey at a tertiary referral centre 157
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 129
What is the Outcome of Patients Affected by Intraductal Papillary Mucinous Neoplasms Without High-Risk Stigmata?: A Single-Center Retrospective Study 122
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 119
Idiopathic myenteric ganglionitis underlying intractable vomiting in a young adult 111
CAR-T cell therapy: A potential new strategy against prostate cancer 103
A clinically applicable integrated molecular, immunohistochemical and histological approach for endometrial carcinoma. 101
Integrated histopathologic and molecular classification of endometri- al carcinoma: identification of prognostic subgroups 99
Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide 97
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives 95
Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy 89
Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: A position paper of the MeetURO Group 87
Ovarian mixed malignant Brenner-mucinous tumour: report of a unique case 83
Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations 80
Real-world experience and clinical impact of drug-drug interactions in HR+/HER2- advanced breast cancer patients treated with abemaciclib plus endocrine therapy: the AB-ITALY study 78
PATHOLOGICAL CHEMOTHERAPY RESPONSE SCORE IN TUBO-OVARIAN HIGH-GRADE SEROUS CARCINOMA: CLINICOPATHOLOGIC AND GENETIC FEATURES 77
Risk stratification for pheochromocytoma and paraganglioma: a comparison of pathological scores for prediction of metastatic potential. 77
Functional stability, progression and evolution of targeted drug sensitivity of HER-2-positive breast cancer patient-derived xenografts 67
Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization 66
Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy? 60
Pathological and immunohistochemical features of ovarian neuroendocrine tumor: a single center experience. 59
Erratum: Microscopic margins of resection influence primary gastrointestinal stromal tumor survival (Onkologie (2012) 35 (645-648)) 38
Pathologic findings in risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA1 or BRCA2 mutations: a single center experience. 37
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 36
Role of Bone Metastases in Patients Receiving Immunotherapy for Pre-Treated Urothelial Carcinoma: The Multicentre, Retrospective Meet-URO-1 Bone Study 27
Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors 16
Totale 6.170
Categoria #
all - tutte 18.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.759


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 0 0 57
2021/2022330 16 9 17 27 30 12 4 14 30 38 95 38
2022/2023669 36 62 28 63 75 66 21 41 143 23 41 70
2023/2024236 28 41 20 21 9 49 7 9 10 14 10 18
2024/20251.082 57 135 73 70 151 57 47 60 20 78 86 248
2025/20263.439 496 261 249 202 255 104 720 116 560 227 128 121
Totale 6.170